Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 14, 2015
0Patent Application Number
132460220
Date Filed
September 27, 2011
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to immunotherapies that are based on myeloid cell depletion. In particular, the present invention relates to CD33 binding agents for use in such therapies, e.g. in the treatment of myeloid cell malignancies and myelodysplastic syndrome (MDS).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
